| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Citrulline | 24 | 2024 | 107 | 9.200 |
Why?
|
| Arginine | 27 | 2024 | 331 | 7.370 |
Why?
|
| Glutamine | 12 | 2018 | 215 | 3.190 |
Why?
|
| Urea | 13 | 2018 | 226 | 2.220 |
Why?
|
| Intestinal Mucosa | 9 | 2020 | 779 | 1.890 |
Why?
|
| Ornithine | 6 | 2012 | 31 | 1.820 |
Why?
|
| Arginase | 4 | 2020 | 31 | 1.750 |
Why?
|
| Nitrogen | 10 | 2017 | 146 | 1.610 |
Why?
|
| Gastrointestinal Tract | 4 | 2018 | 215 | 1.490 |
Why?
|
| Nutritional Requirements | 4 | 2017 | 181 | 1.460 |
Why?
|
| Ornithine Carbamoyltransferase Deficiency Disease | 7 | 2018 | 34 | 1.440 |
Why?
|
| Polyethylene Glycols | 4 | 2024 | 224 | 1.420 |
Why?
|
| Nitric Oxide | 8 | 2018 | 444 | 1.390 |
Why?
|
| Hydrolases | 4 | 2024 | 54 | 1.380 |
Why?
|
| Swine | 12 | 2024 | 1177 | 1.370 |
Why?
|
| Kidney | 8 | 2020 | 1353 | 1.290 |
Why?
|
| Nitrogen Isotopes | 8 | 2018 | 63 | 1.250 |
Why?
|
| Ornithine Carbamoyltransferase | 5 | 2018 | 17 | 1.160 |
Why?
|
| Phenylbutyrates | 4 | 2017 | 58 | 1.080 |
Why?
|
| Amino Acids | 6 | 2020 | 663 | 1.040 |
Why?
|
| Animals | 59 | 2024 | 34038 | 1.030 |
Why?
|
| Animals, Newborn | 10 | 2020 | 1006 | 1.030 |
Why?
|
| Diet | 6 | 2017 | 1133 | 0.840 |
Why?
|
| Mice | 34 | 2022 | 17618 | 0.800 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2020 | 256 | 0.790 |
Why?
|
| Cattle | 5 | 2007 | 565 | 0.780 |
Why?
|
| Mice, Inbred ICR | 7 | 2018 | 152 | 0.750 |
Why?
|
| Glycine | 2 | 2020 | 168 | 0.690 |
Why?
|
| Duodenum | 1 | 2020 | 99 | 0.680 |
Why?
|
| Jejunum | 1 | 2020 | 129 | 0.670 |
Why?
|
| Carbon Isotopes | 6 | 2017 | 276 | 0.620 |
Why?
|
| Mice, Inbred C57BL | 13 | 2020 | 4397 | 0.610 |
Why?
|
| Proline | 4 | 2012 | 78 | 0.600 |
Why?
|
| Endotoxins | 1 | 2018 | 48 | 0.590 |
Why?
|
| Dietary Supplements | 3 | 2017 | 476 | 0.580 |
Why?
|
| Urea Cycle Disorders, Inborn | 2 | 2020 | 77 | 0.580 |
Why?
|
| Benzoates | 1 | 2017 | 20 | 0.570 |
Why?
|
| Male | 40 | 2024 | 60998 | 0.550 |
Why?
|
| Growth | 1 | 2017 | 106 | 0.540 |
Why?
|
| Fetal Development | 1 | 2018 | 132 | 0.540 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2020 | 997 | 0.530 |
Why?
|
| Enterocolitis, Necrotizing | 2 | 2020 | 243 | 0.520 |
Why?
|
| Hyperammonemia | 2 | 2006 | 62 | 0.500 |
Why?
|
| Dietary Proteins | 3 | 2014 | 251 | 0.500 |
Why?
|
| Aging | 2 | 2019 | 1165 | 0.500 |
Why?
|
| Sex Characteristics | 1 | 2017 | 314 | 0.490 |
Why?
|
| Biological Availability | 4 | 2021 | 135 | 0.470 |
Why?
|
| Intestines | 1 | 2018 | 573 | 0.460 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2014 | 93 | 0.450 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2014 | 48 | 0.450 |
Why?
|
| Muscle Proteins | 2 | 2015 | 417 | 0.440 |
Why?
|
| Intestine, Small | 4 | 2019 | 312 | 0.430 |
Why?
|
| Argininosuccinate Lyase | 4 | 2020 | 57 | 0.430 |
Why?
|
| Muscle, Skeletal | 3 | 2015 | 942 | 0.420 |
Why?
|
| Sus scrofa | 3 | 2020 | 125 | 0.410 |
Why?
|
| Biosynthetic Pathways | 1 | 2012 | 25 | 0.410 |
Why?
|
| Membrane Transport Proteins | 2 | 2004 | 176 | 0.390 |
Why?
|
| Liver | 7 | 2018 | 1733 | 0.390 |
Why?
|
| Mice, Mutant Strains | 6 | 2018 | 383 | 0.380 |
Why?
|
| Renal Insufficiency | 1 | 2014 | 235 | 0.380 |
Why?
|
| Ammonia | 6 | 2010 | 74 | 0.380 |
Why?
|
| Rumen | 4 | 2005 | 13 | 0.380 |
Why?
|
| Digestion | 3 | 2009 | 41 | 0.380 |
Why?
|
| Amino Acids, Branched-Chain | 2 | 2011 | 77 | 0.370 |
Why?
|
| Female | 32 | 2024 | 66275 | 0.370 |
Why?
|
| Metabolic Networks and Pathways | 4 | 2018 | 187 | 0.370 |
Why?
|
| Disease Models, Animal | 12 | 2024 | 4342 | 0.370 |
Why?
|
| Mutation | 3 | 2018 | 5817 | 0.370 |
Why?
|
| Gestational Age | 2 | 2015 | 1159 | 0.370 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2011 | 48 | 0.360 |
Why?
|
| Models, Biological | 5 | 2014 | 1454 | 0.360 |
Why?
|
| Random Allocation | 5 | 2017 | 436 | 0.350 |
Why?
|
| Dipeptides | 3 | 2018 | 58 | 0.330 |
Why?
|
| Isotope Labeling | 3 | 2018 | 104 | 0.320 |
Why?
|
| Parenteral Nutrition | 4 | 2020 | 194 | 0.310 |
Why?
|
| Mice, Knockout | 8 | 2020 | 3725 | 0.310 |
Why?
|
| Mass Spectrometry | 2 | 2010 | 329 | 0.310 |
Why?
|
| Models, Animal | 3 | 2020 | 459 | 0.310 |
Why?
|
| Glucose Intolerance | 2 | 2022 | 78 | 0.300 |
Why?
|
| Tumor Microenvironment | 3 | 2017 | 549 | 0.300 |
Why?
|
| Argininosuccinic Aciduria | 4 | 2012 | 47 | 0.300 |
Why?
|
| Kinetics | 4 | 2021 | 1321 | 0.300 |
Why?
|
| Insulin Resistance | 3 | 2022 | 637 | 0.290 |
Why?
|
| Glutaredoxins | 2 | 2019 | 30 | 0.290 |
Why?
|
| Infusions, Intravenous | 3 | 2018 | 547 | 0.280 |
Why?
|
| Citric Acid Cycle | 3 | 2017 | 47 | 0.280 |
Why?
|
| Lipopolysaccharides | 2 | 2024 | 292 | 0.280 |
Why?
|
| Feces | 3 | 2005 | 724 | 0.270 |
Why?
|
| Glycolysis | 3 | 2017 | 148 | 0.270 |
Why?
|
| Animals, Laboratory | 1 | 2006 | 12 | 0.270 |
Why?
|
| Weaning | 2 | 2017 | 44 | 0.260 |
Why?
|
| Flow Injection Analysis | 1 | 2006 | 3 | 0.260 |
Why?
|
| Blood Specimen Collection | 1 | 2006 | 49 | 0.260 |
Why?
|
| Exosomes | 2 | 2017 | 43 | 0.260 |
Why?
|
| Phenylalanine | 4 | 2010 | 125 | 0.260 |
Why?
|
| Deuterium | 3 | 2017 | 109 | 0.250 |
Why?
|
| Liver Diseases | 3 | 2020 | 365 | 0.250 |
Why?
|
| Proteins | 1 | 2011 | 1036 | 0.250 |
Why?
|
| Urinalysis | 1 | 2006 | 61 | 0.250 |
Why?
|
| Carrier Proteins | 2 | 2017 | 1022 | 0.240 |
Why?
|
| Catheterization | 1 | 2006 | 235 | 0.230 |
Why?
|
| Energy Metabolism | 3 | 2014 | 774 | 0.220 |
Why?
|
| Endotoxemia | 1 | 2024 | 58 | 0.220 |
Why?
|
| Sheep | 1 | 2004 | 219 | 0.220 |
Why?
|
| Specific Pathogen-Free Organisms | 3 | 2010 | 52 | 0.220 |
Why?
|
| Glucose | 4 | 2022 | 879 | 0.200 |
Why?
|
| Short Bowel Syndrome | 2 | 2020 | 65 | 0.190 |
Why?
|
| Genotype | 4 | 2020 | 2556 | 0.190 |
Why?
|
| Osteogenesis Imperfecta | 2 | 2014 | 148 | 0.190 |
Why?
|
| Neoplasms | 4 | 2017 | 2765 | 0.190 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2022 | 58 | 0.180 |
Why?
|
| Argininosuccinate Synthase | 2 | 2018 | 21 | 0.180 |
Why?
|
| Membrane Glycoproteins | 1 | 2003 | 409 | 0.170 |
Why?
|
| Ovarian Neoplasms | 2 | 2014 | 417 | 0.170 |
Why?
|
| Tissue Distribution | 1 | 2021 | 382 | 0.170 |
Why?
|
| Liver Glycogen | 1 | 2020 | 23 | 0.170 |
Why?
|
| Colitis | 2 | 2012 | 153 | 0.170 |
Why?
|
| Lactation | 2 | 2016 | 193 | 0.170 |
Why?
|
| Reactive Oxygen Species | 3 | 2019 | 483 | 0.160 |
Why?
|
| Glucagon-Like Peptide 2 | 1 | 2019 | 54 | 0.160 |
Why?
|
| Animal Feed | 2 | 2017 | 79 | 0.150 |
Why?
|
| Tissue Culture Techniques | 1 | 2018 | 70 | 0.150 |
Why?
|
| Vasomotor System | 1 | 2018 | 25 | 0.150 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 2020 | 193 | 0.150 |
Why?
|
| Cardiomegaly | 1 | 2019 | 130 | 0.150 |
Why?
|
| Cell Proliferation | 5 | 2019 | 2284 | 0.140 |
Why?
|
| Animals, Domestic | 1 | 2017 | 31 | 0.140 |
Why?
|
| Healthy Volunteers | 1 | 2017 | 131 | 0.140 |
Why?
|
| Glutamate-Ammonia Ligase | 1 | 2016 | 11 | 0.140 |
Why?
|
| Organ Culture Techniques | 1 | 2017 | 155 | 0.140 |
Why?
|
| Cells, Cultured | 3 | 2019 | 3036 | 0.130 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2019 | 292 | 0.130 |
Why?
|
| Enteral Nutrition | 1 | 2018 | 255 | 0.130 |
Why?
|
| Sex Factors | 2 | 2017 | 1277 | 0.130 |
Why?
|
| Gene Editing | 1 | 2018 | 187 | 0.130 |
Why?
|
| Species Specificity | 1 | 2017 | 549 | 0.130 |
Why?
|
| Cell Communication | 1 | 2017 | 165 | 0.130 |
Why?
|
| Fibroblasts | 3 | 2016 | 883 | 0.130 |
Why?
|
| CRISPR-Cas Systems | 1 | 2018 | 254 | 0.130 |
Why?
|
| Thinness | 1 | 2016 | 70 | 0.120 |
Why?
|
| Carbamoyl-Phosphate Synthase (Ammonia) | 1 | 2015 | 7 | 0.120 |
Why?
|
| Epithelial Cells | 2 | 2016 | 909 | 0.120 |
Why?
|
| Regression Analysis | 2 | 2007 | 777 | 0.120 |
Why?
|
| Diet, Protein-Restricted | 1 | 2016 | 81 | 0.120 |
Why?
|
| Vitamin E | 1 | 2015 | 67 | 0.120 |
Why?
|
| Humans | 21 | 2020 | 124175 | 0.120 |
Why?
|
| Anabolic Agents | 1 | 2014 | 14 | 0.110 |
Why?
|
| Ligation | 1 | 2014 | 135 | 0.110 |
Why?
|
| Fat Emulsions, Intravenous | 1 | 2015 | 76 | 0.110 |
Why?
|
| Pregnancy | 4 | 2016 | 7174 | 0.110 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2017 | 1230 | 0.110 |
Why?
|
| Blood Urea Nitrogen | 2 | 2004 | 73 | 0.110 |
Why?
|
| Alendronate | 1 | 2013 | 19 | 0.110 |
Why?
|
| Adult | 7 | 2017 | 29339 | 0.110 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2014 | 126 | 0.110 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2016 | 225 | 0.110 |
Why?
|
| Fracture Healing | 1 | 2013 | 28 | 0.110 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2014 | 61 | 0.110 |
Why?
|
| Mammary Glands, Animal | 1 | 2016 | 481 | 0.110 |
Why?
|
| Nephrectomy | 1 | 2014 | 177 | 0.100 |
Why?
|
| Premature Birth | 1 | 2017 | 385 | 0.100 |
Why?
|
| Radioactive Tracers | 1 | 2012 | 21 | 0.100 |
Why?
|
| Middle Aged | 5 | 2017 | 26588 | 0.100 |
Why?
|
| Inflammation | 4 | 2024 | 1428 | 0.100 |
Why?
|
| Thionucleosides | 1 | 2012 | 6 | 0.100 |
Why?
|
| Genetic Markers | 1 | 2014 | 604 | 0.100 |
Why?
|
| Glycogenolysis | 1 | 2012 | 10 | 0.100 |
Why?
|
| Ghrelin | 1 | 2012 | 53 | 0.100 |
Why?
|
| Bone Density | 1 | 2014 | 318 | 0.090 |
Why?
|
| Dansyl Compounds | 1 | 2011 | 4 | 0.090 |
Why?
|
| Vitamin B 6 Deficiency | 1 | 2011 | 6 | 0.090 |
Why?
|
| Gluconeogenesis | 1 | 2012 | 106 | 0.090 |
Why?
|
| Adenosine | 1 | 2012 | 127 | 0.090 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2011 | 40 | 0.090 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2011 | 95 | 0.090 |
Why?
|
| Maple Syrup Urine Disease | 1 | 2010 | 16 | 0.090 |
Why?
|
| Food Deprivation | 2 | 2012 | 32 | 0.090 |
Why?
|
| Protein Biosynthesis | 1 | 2014 | 664 | 0.090 |
Why?
|
| Methionine | 1 | 2011 | 102 | 0.090 |
Why?
|
| Homocysteine | 1 | 2011 | 122 | 0.090 |
Why?
|
| Phenotype | 3 | 2018 | 4251 | 0.090 |
Why?
|
| Antibodies, Neutralizing | 1 | 2014 | 467 | 0.090 |
Why?
|
| Rats | 1 | 2017 | 3675 | 0.090 |
Why?
|
| Injections, Intravenous | 2 | 2007 | 253 | 0.080 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2012 | 307 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2004 | 1688 | 0.080 |
Why?
|
| Cytokines | 2 | 2024 | 1287 | 0.080 |
Why?
|
| Mitochondria | 1 | 2014 | 679 | 0.080 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2011 | 235 | 0.080 |
Why?
|
| alpha-Glucosidases | 1 | 2009 | 28 | 0.080 |
Why?
|
| Starch | 1 | 2009 | 25 | 0.080 |
Why?
|
| Cell Line, Tumor | 4 | 2017 | 3328 | 0.080 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2011 | 680 | 0.070 |
Why?
|
| Gene Expression Regulation | 1 | 2017 | 2521 | 0.070 |
Why?
|
| Genetic Therapy | 1 | 2012 | 678 | 0.070 |
Why?
|
| Germ-Free Life | 1 | 2007 | 60 | 0.070 |
Why?
|
| Mice, Inbred Strains | 1 | 2007 | 307 | 0.070 |
Why?
|
| Alanine | 1 | 2007 | 182 | 0.070 |
Why?
|
| Mountaineering | 1 | 2006 | 2 | 0.070 |
Why?
|
| Alanine Transaminase | 2 | 2020 | 155 | 0.060 |
Why?
|
| Altitude | 1 | 2006 | 24 | 0.060 |
Why?
|
| Insulin | 3 | 2022 | 1200 | 0.060 |
Why?
|
| Dietary Fiber | 2 | 2003 | 74 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2016 | 1260 | 0.060 |
Why?
|
| Heart Failure | 1 | 2019 | 2287 | 0.060 |
Why?
|
| Maze Learning | 1 | 2006 | 128 | 0.060 |
Why?
|
| Fasting | 2 | 2022 | 299 | 0.060 |
Why?
|
| Environmental Pollution | 1 | 2005 | 12 | 0.060 |
Why?
|
| Aspartate Aminotransferases | 2 | 2016 | 81 | 0.060 |
Why?
|
| Homeostasis | 1 | 2009 | 685 | 0.060 |
Why?
|
| Attention | 1 | 2006 | 187 | 0.060 |
Why?
|
| Enzymes | 1 | 2004 | 52 | 0.060 |
Why?
|
| Social Behavior | 1 | 2006 | 209 | 0.060 |
Why?
|
| Urease | 1 | 2004 | 73 | 0.060 |
Why?
|
| Bacteria | 1 | 2007 | 484 | 0.060 |
Why?
|
| X-Ray Microtomography | 2 | 2014 | 83 | 0.050 |
Why?
|
| Adolescent | 5 | 2012 | 19243 | 0.050 |
Why?
|
| Young Adult | 3 | 2012 | 8990 | 0.050 |
Why?
|
| Organ Size | 1 | 2004 | 426 | 0.050 |
Why?
|
| Memory | 1 | 2006 | 362 | 0.050 |
Why?
|
| Body Mass Index | 2 | 2022 | 1555 | 0.050 |
Why?
|
| Energy Intake | 1 | 2005 | 493 | 0.050 |
Why?
|
| Creatinine | 1 | 2004 | 388 | 0.050 |
Why?
|
| Weight Loss | 1 | 2006 | 480 | 0.050 |
Why?
|
| Infant, Premature | 2 | 2020 | 813 | 0.050 |
Why?
|
| Dextran Sulfate | 2 | 2012 | 48 | 0.050 |
Why?
|
| Milk | 1 | 2002 | 119 | 0.050 |
Why?
|
| Peroxidase | 2 | 2012 | 62 | 0.050 |
Why?
|
| Glutathione | 2 | 2014 | 193 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 2041 | 0.040 |
Why?
|
| Analysis of Variance | 2 | 2014 | 1008 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2007 | 1699 | 0.040 |
Why?
|
| Isoenzymes | 2 | 2014 | 229 | 0.040 |
Why?
|
| Enteroendocrine Cells | 1 | 2019 | 21 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2006 | 2863 | 0.040 |
Why?
|
| Oxidoreductases | 1 | 2018 | 91 | 0.040 |
Why?
|
| RNA, Messenger | 2 | 2016 | 2815 | 0.040 |
Why?
|
| Adaptation, Physiological | 1 | 2019 | 271 | 0.040 |
Why?
|
| Plasmids | 1 | 2018 | 510 | 0.030 |
Why?
|
| Calcium Signaling | 1 | 2019 | 243 | 0.030 |
Why?
|
| Hepatocytes | 1 | 2018 | 207 | 0.030 |
Why?
|
| Receptor Activator of Nuclear Factor-kappa B | 1 | 2016 | 16 | 0.030 |
Why?
|
| Gene Expression | 2 | 2012 | 1561 | 0.030 |
Why?
|
| Child | 3 | 2012 | 24356 | 0.030 |
Why?
|
| Signal Transduction | 3 | 2016 | 4505 | 0.030 |
Why?
|
| Cancer-Associated Fibroblasts | 1 | 2016 | 16 | 0.030 |
Why?
|
| Cyclin D1 | 1 | 2016 | 112 | 0.030 |
Why?
|
| Nucleotides | 1 | 2016 | 92 | 0.030 |
Why?
|
| RANK Ligand | 1 | 2016 | 52 | 0.030 |
Why?
|
| Pregnancy, Animal | 1 | 2016 | 76 | 0.030 |
Why?
|
| Milk Proteins | 1 | 2016 | 92 | 0.030 |
Why?
|
| Carbon | 1 | 2016 | 91 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 1318 | 0.030 |
Why?
|
| Body Fat Distribution | 1 | 2016 | 28 | 0.030 |
Why?
|
| Fermentation | 1 | 2016 | 66 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2020 | 1179 | 0.030 |
Why?
|
| Oxidative Phosphorylation | 1 | 2016 | 107 | 0.030 |
Why?
|
| Lactic Acid | 1 | 2016 | 153 | 0.030 |
Why?
|
| Stromal Cells | 1 | 2016 | 299 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2016 | 707 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2016 | 359 | 0.030 |
Why?
|
| Phytosterols | 1 | 2015 | 28 | 0.030 |
Why?
|
| Soybean Oil | 1 | 2015 | 70 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2016 | 503 | 0.030 |
Why?
|
| Tartrate-Resistant Acid Phosphatase | 1 | 2014 | 3 | 0.030 |
Why?
|
| Acid Phosphatase | 1 | 2014 | 14 | 0.030 |
Why?
|
| Infant, Newborn | 2 | 2020 | 8188 | 0.030 |
Why?
|
| Fish Oils | 1 | 2015 | 83 | 0.030 |
Why?
|
| NADP | 1 | 2014 | 49 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2016 | 455 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2016 | 1102 | 0.030 |
Why?
|
| Metabolome | 1 | 2016 | 293 | 0.030 |
Why?
|
| Myocytes, Cardiac | 1 | 2019 | 603 | 0.030 |
Why?
|
| Osteocalcin | 1 | 2014 | 42 | 0.030 |
Why?
|
| Mice, Inbred mdx | 1 | 2014 | 39 | 0.030 |
Why?
|
| Femur | 1 | 2014 | 67 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2014 | 151 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2016 | 862 | 0.030 |
Why?
|
| Stress, Mechanical | 1 | 2014 | 167 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2019 | 799 | 0.030 |
Why?
|
| Bony Callus | 1 | 2013 | 3 | 0.030 |
Why?
|
| Densitometry | 1 | 2013 | 25 | 0.030 |
Why?
|
| Spectrum Analysis, Raman | 1 | 2013 | 27 | 0.030 |
Why?
|
| Aged | 1 | 2011 | 19533 | 0.030 |
Why?
|
| Osteogenesis | 1 | 2014 | 154 | 0.030 |
Why?
|
| Argininosuccinic Acid | 1 | 2012 | 7 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 1689 | 0.030 |
Why?
|
| Adipose Tissue | 1 | 2016 | 461 | 0.030 |
Why?
|
| Receptors, Progesterone | 1 | 2016 | 878 | 0.030 |
Why?
|
| Liver Function Tests | 1 | 2012 | 100 | 0.030 |
Why?
|
| Biomechanical Phenomena | 1 | 2013 | 225 | 0.020 |
Why?
|
| Receptors, Ghrelin | 1 | 2012 | 28 | 0.020 |
Why?
|
| Placebos | 1 | 2012 | 240 | 0.020 |
Why?
|
| Child, Preschool | 3 | 2012 | 13997 | 0.020 |
Why?
|
| Nitrites | 1 | 2011 | 46 | 0.020 |
Why?
|
| Eating | 1 | 2014 | 374 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2014 | 608 | 0.020 |
Why?
|
| Pyridoxal Phosphate | 1 | 2011 | 14 | 0.020 |
Why?
|
| S-Adenosylhomocysteine | 1 | 2011 | 16 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2012 | 229 | 0.020 |
Why?
|
| Methylmalonic Acid | 1 | 2011 | 15 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 2012 | 310 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2012 | 341 | 0.020 |
Why?
|
| Nitric Oxide Synthase | 1 | 2011 | 186 | 0.020 |
Why?
|
| Body Composition | 1 | 2014 | 522 | 0.020 |
Why?
|
| 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide) | 1 | 2010 | 10 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2012 | 722 | 0.020 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2010 | 76 | 0.020 |
Why?
|
| Keto Acids | 1 | 2010 | 56 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2014 | 541 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2011 | 353 | 0.020 |
Why?
|
| Interleukin-10 | 1 | 2011 | 173 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2011 | 660 | 0.020 |
Why?
|
| Sucrase | 1 | 2009 | 23 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2012 | 1162 | 0.020 |
Why?
|
| Mucous Membrane | 1 | 2009 | 88 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2012 | 1629 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2011 | 1032 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2011 | 521 | 0.020 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2012 | 303 | 0.020 |
Why?
|
| Metabolomics | 1 | 2011 | 421 | 0.020 |
Why?
|
| Electron Transport | 1 | 2007 | 53 | 0.020 |
Why?
|
| Age Factors | 1 | 2014 | 2806 | 0.020 |
Why?
|
| Immunity, Mucosal | 1 | 2007 | 87 | 0.020 |
Why?
|
| Host-Parasite Interactions | 1 | 2007 | 70 | 0.020 |
Why?
|
| Body Weight | 1 | 2011 | 995 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2007 | 142 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2010 | 1616 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2014 | 1891 | 0.020 |
Why?
|
| Methylhistidines | 1 | 2006 | 10 | 0.020 |
Why?
|
| Cell Line | 1 | 2011 | 2744 | 0.020 |
Why?
|
| Alkalosis | 1 | 2006 | 24 | 0.020 |
Why?
|
| Thyrotropin | 1 | 2006 | 57 | 0.020 |
Why?
|
| Triiodothyronine | 1 | 2006 | 62 | 0.020 |
Why?
|
| Thyroxine | 1 | 2006 | 66 | 0.020 |
Why?
|
| Biomarkers | 1 | 2015 | 3050 | 0.020 |
Why?
|
| Hydrocortisone | 1 | 2006 | 217 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2011 | 1748 | 0.020 |
Why?
|
| Carbamoyl-Phosphate Synthase I Deficiency Disease | 1 | 2004 | 5 | 0.010 |
Why?
|
| Gene Regulatory Networks | 1 | 2007 | 350 | 0.010 |
Why?
|
| Hyperargininemia | 1 | 2004 | 13 | 0.010 |
Why?
|
| Prognosis | 1 | 2014 | 4609 | 0.010 |
Why?
|
| Hypoxia | 1 | 2006 | 248 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 3549 | 0.010 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2006 | 340 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2007 | 1015 | 0.010 |
Why?
|
| Environmental Exposure | 1 | 2006 | 221 | 0.010 |
Why?
|
| Hypertension | 1 | 2012 | 1316 | 0.010 |
Why?
|
| Carrier State | 1 | 2003 | 77 | 0.010 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2004 | 114 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2019 | 12288 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2011 | 2882 | 0.010 |
Why?
|
| Animal Nutritional Physiological Phenomena | 1 | 2002 | 63 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2007 | 1696 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2003 | 681 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2007 | 1890 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2006 | 5132 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2003 | 3266 | 0.010 |
Why?
|